Kraig Biocraft Laboratories Announces New Independent Registered Accounting Firm
October 31 2013 - 6:05AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the
leading developer of advanced spider silk based fibers, announced
today that it has appointed M&K CPAs ("M&K") as the
Company's new independent registered public accounting firm and has
thereby dismissed PS Stephenson & Co, P.C. ("Stephenson") from
that role. The decision to engage M&K was made by the Company's
audit committee, acting on behalf of the Company's board of
directors, on October 28, 2013.
"As a result of the Company's changing needs, as it advances
toward commercialization of recombinant fibers, and after
consulting with our Stephenson representative, we determined that
it would be best to engage a new, larger accounting firm that is
positioned to address our future needs. Therefore, we are very
pleased to engage M&K as our independent auditors."
"We appreciate Stephenson's expert service, which they've
proficiently provided for the past two years, and we would like to
thank them for their professionalism," said Kraig CEO and founder,
Kim K. Thompson.
The Company had no unresolved disagreements with Stephenson,
during the two most recent fiscal years and through the date of
this release, on any matter of accounting principles or practices,
financial statement disclosure, or auditing scope or
procedure. The move to M&K as the Company's registered
accounting firm was made in consideration of M&K's considerable
expertise and the Company's changing needs as it moves toward
commercialization.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Apr 2023 to Apr 2024